Fund Holdings — Fairmount Funds Management LLC

Total Portfolio Value:
$946.46M
Total Bought:
$97.02M
Total Sold:
$136.55M
Net Transaction:
-$39.52M
Notable People:
Tomas Kiselak, Peter Evan Harwin
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Axsome Therapeutics, Inc.(AXSM)2,341,2382,360,077+18,839$163.63M$187.84M19.85%+$24.21M
Immunogen Inc5,929,5925,929,5920$94.10M$175.81M18.58%+$81.71M
Nuvalent Inc2,451,8191,924,626-527,193$112.71M$141.63M14.96%+$28.92M
Apogee Therapeutics Inc2,941,1762,941,1760$62.65M$82.18M8.68%+$19.53M
Rayzebio Inc1,221,9041,245,929+24,025$27.13M$77.46M8.18%+$50.33M
Kiniksa Pharmaceuticals LtdCL A2,474,5612,883,221+408,660$42.98M$50.57M5.34%+$7.59M
argenx SEADR(ARGX)83,747112,903+29,156$41.17M$42.95M4.54%+$1.78M
Viridian Therapeutics, Inc.(VRDN)1,369,6231,369,6230$21.01M$29.83M3.15%+$8.82M
Enliven Therapeutics Inc2,131,3692,131,3690$29.11M$29.50M3.12%+$383.6K
Astria Therapeutics Inc1,901,3973,554,129+1,652,732$14.18M$27.30M2.88%+$13.11M
Cogent Biosciences, Inc.(COGT)3,558,9753,558,9750$34.70M$20.93M2.21%-$13.77M
Dianthus Therapeutics, Inc.(DNTH)1,928,5031,928,5030$26.36M$20.06M2.12%-$6.31M
Merus N V1,881,345717,254-1,164,091$44.36M$19.72M2.08%-$24.64M
Tyra Biosciences, Inc.(TYRA)1,393,3291,393,3290$19.19M$19.30M2.04%+$111.5K
Terns Pharmaceuticals Inc2,040,0002,040,0000$10.26M$13.24M1.40%+$2.98M
Spyre Therapeutics, Inc.(SYRE)378,421378,4210$4.64M$8.14M0.86%+$3.51M
DBV TECHNOLOGIES SASPONSORED ADR6,781,1500-6,781,150$9.22M$0—-$9.22M
IMMUNOVANT INCCOM(IMVT)750,0000-750,000$28.79M$0—-$28.79M
SOLENO THERAPEUTICS INCCOM1,142,4730-1,142,473$33.71M$0—-$33.71M
TREVI THERAPEUTICS INCCOM(TRVI)5,163,2870-5,163,287$11.26M$0—-$11.26M
Page 1 of 1